tibljТуберкулез и болезни легкихTuberculosis and Lung Diseases2075-12302542-1506Медицинские знания и технологии10.21292/2075-1230-2022-100-4-62-66tiblj-1635Research ArticleОБЗОРЫREVIEWSИспользование мезенхимных стволовых клеток в терапии туберкулезаUse of mesenchymal stem cells in therapy of tuberculosishttps://orcid.org/0000-0001-8145-4159РемезоваА. Н.RemezovaА. N.

Ремезова Анна Николаевна, ординатор кафедры госпитальной хирургии

199034, Санкт-Петербург, Университетская наб., д. 7-9

Anna N. Remezova, Resident Physician of Hospital Surgery Department

7-9, Universitetskaya Nab., St. Petersburg, 199034

urolog-remezovaanna@yandex.ruhttps://orcid.org/0000-0002-7010-7562ГореловаА. А.GorelovaА. А.

Горелова Анна Андреевна, ассистент

191036, Санкт-Петербург, Лиговский пр., д. 2-4

199034, Санкт-Петербург, Университетская наб., д. 7-9

Anna A. Gorelova, Assistant

2-4, Ligovsky Ave., St. Petersburg, 191036

7-9, Universitetskaya Nab., St. Petersburg, 199034

gorelova_a@yahoo.comhttps://orcid.org/0000-0002-5234-349XВиноградоваТ. И.VinogradovaT. I.

Виноградова Татьяна Ивановна, доктор медицинских наук, профессор, главный научный сотрудник

191036, Санкт-Петербург, Лиговский пр., д. 2-4

 

Tatyana I. Vinogradova, Doctor of Medical Sciences, Professor, Senior Researcher

2-4, Ligovsky Ave., St. Petersburg, 191036

vinogradova@spbniif.ruhttps://orcid.org/0000-0002-2858-5317ГореловА. И.GorelovА. I.

Горелов Андрей Игоревич, доктор медицинских наук, профессор, профессор кафедры урологии медицинского факультета

199034, Санкт-Петербург, Университетская наб., д. 7-9

Andrey I. Gorelov, Doctor of Medical Sciences, Professor, Professor of Urology Department, Medicine Faculty

7-9, Universitetskaya Nab., St. Petersburg, 199034

gorelov_a_i@mail.ruhttps://orcid.org/0000-0002-0656-4187ГорбуновА. И.GorbunovА. I.

Горбунов Александр Игоревич, младший научный сотрудник направления «Урология, гинекология и абдоминальная хирургия»

191036, Санкт-Петербург, Лиговский пр., д. 2-4

Aleksandr I. Gorbunov, Researcher in Urology, Gynecology and Abdominal Surgery

2-4, Ligovsky Ave., St. Petersburg, 191036

alx.urolog@gmail.comhttps://orcid.org/0000-0002-7357-1571ЮдинцеваН. М.YudintsevaN. M.

Юдинцева Наталия Михайловна, кандидат биологических наук, старший научный сотрудник

194064, Санкт-Петербург, Тихорецкий просп., д. 4

Natalia M. Yudintseva, Candidate of Biological Sciences, Senior Researcher

4, Tikhoretskiy Ave., St. Petersburg 194064

yudintceva@mail.ruФГБОУ ВО «Санкт-Петербургский государственный университет»РоссияSt. Petersburg UniversityRussian FederationФГБУ «Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии» МЗ РФ; ФГБОУ ВО «Санкт-Петербургский государственный университет»РоссияSt. Petersburg Research Institute of Phthisiopulmonology; St. Petersburg UniversityRussian FederationФГБУ «Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии» МЗ РФРоссияSt. Petersburg Research Institute of PhthisiopulmonologyRussian FederationФГБОУ ВО «Санкт-Петербургский государственный университет»;СПБ ГБУЗ «Городская Покровская больница»РоссияSt. Petersburg University; Pokrovskaya City HospitalRussian FederationФГБУН «Институт цитологии Российской академии наук (ИНЦ РАН)»РоссияInstitute of Cytology, the Russian Academy of SciencesRussian Federation20221405202210046266Copyright © Ремезова А.Н., Горелова А.А., Виноградова Т.И., Горелов А.И., Горбунов А.И., Юдинцева Н.М., 20222022Ремезова А.Н., Горелова А.А., Виноградова Т.И., Горелов А.И., Горбунов А.И., Юдинцева Н.М.Remezova А.N., Gorelova А.А., Vinogradova T.I., Gorelov А.I., Gorbunov А.I., Yudintseva N.M.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.tibl-journal.com/jour/article/view/1635

В обзоре представлены данные из 29 источников литературы, посвященных использованию мезенхимных стволовых клеток в терапии туберкулеза различной локализации. Также описаны некоторые механизмы взаимодействия мезенхимных стволовых клеток с M. tuberculosis.

This review presents data from 29 publications on the use of mesenchymal stem cells in the therapy of tuberculosis of various localizations. It also describes some mechanisms of interaction between mesenchymal stem cells and M. tuberculosis.

мезенхимные стволовые клеткитуберкулезмножественная лекарственная устойчивостьmesenchymal stem cellstuberculosismultiple drug resistanceReferencesАриэль Б. М., Гусейнова Ф. М., Виноградова Т. И. и др. Мезенхимные клетки стромы костного мозга при туберкулезе гениталий у кроликов (экспериментальное исследование с морфологическим контролем) // Обзоры по клинической фармакологии и лекарственной терапии. ‒ 2017. ‒ Т. 15, № 2. ‒ С. 47-55.Аriel B.M., Guseynova F.M., Vinogradova T.I. et al. Mesenchymal stem cells of the bone marrow in treatment of genital tuberculosis in rabbits (experimental research with morphological control). Obzory Po Klinicheskoy Farmakologii I Lekarstvennoy Terapii, 2017, vol. 15, no. 2, pp. 47-55. (In Russ.)Гусейнова Ф. М., Виноградова Т. И., Заболотных Н. В. и др. Влияние клеточной терапии мезенхимными клетками стромы костного мозга на процессы репарации при экспериментальном туберкулезном сальпингите // Медицинский альянс. – 2017. – № 3. – С. 35-43.Guseynova F.M., Vinogradova T.I., Zabolotnykh N.V. at al. The impact of cellular therapy with mesenchymal stem cells of bone marrow on reparation at experimental tuberculous salpingitis. Meditsinsky Alyans, 2017, no. 3, pp. 35-43. (In Russ.)Ерохин В. В., Васильева И. А., Коноплянников А. Г. и др. Системная трансплантация аутологичных мезенхимальных стволовых клеток костного мозга в лечении больных множественным лекарственно-устойчивым туберкулезом легких // Туб. и болезни легких. – 2008. – Т. 85, № 10. – С. 3-6.Erokhin V.V., Vasilyeva I.А., Konoplyannikov А.G. et al. System transplantation of self-specific mesenchymal bone marrow stem cells for treatment of multiple drug resistant pulmonary tuberculosis patients. Tuberculosis and Lung Diseases, 2008, vol. 85, no. 10, pp. 3-6. (In Russ.)Орлова Н. В., Муравьев А. Н., Блюм Н. М. и др. Экспериментальная реконструкция мочевого пузыря кролика с использованием аллогенных клеток различного тканевого происхождения // Медицинский альянс. – 2016. – № 1. – С. 50-52.Orlova N.V., Muraviev А.N., Blyum N.M. at al. Experimental urinary bladder reconstruction in the rabbit using self-specific cells of various tissue origin. Meditsinsky Alyans, 2016, no. 1, pp. 50-52. (In Russ.)Cohen K. A., Abeel T., McGuire A. M. et al. Evolution of extensively drug-resistant tuberculosis over four decades revealed by whole genome sequencing of Mycobacterium tuberculosis from KwaZulu-Natal, South Africa // Intern. J. Mycobacter. – 2015. – Vol. 4. – P. 24-25. doi:10.1016/j.ijmyco.2014.11.028.Cohen K.A., Abeel T., McGuire A.M. et al. Evolution of extensively drug-resistant tuberculosis over four decades revealed by whole genome sequencing of Mycobacterium tuberculosis from KwaZulu-Natal, South Africa. Intern. J. Mycobacter., 2015, vol. 4, pp. 24-25. doi:10.1016/j.ijmyco.2014.11.028.Danjuma L., Mok P. L., Higuchi A. et al. Modulatory and regenerative potential of transplanted bone marrow-derived mesenchymal stem cells on rifampicin-induced kidney toxicity // Regenera. Ther. – 2018. – Vol. 9. – P. 100-110. doi:10.1016/j.reth.2018.09.001.Danjuma L., Mok P.L., Higuchi A. et al. Modulatory and regenerative potential of transplanted bone marrow-derived mesenchymal stem cells on rifampicin-induced kidney toxicity. Regenera. Ther., 2018, vol. 9, pp. 100-110. doi:10.1016/j.reth.2018.09.001.Das B., Kashino S. S., Pulu I. et al. CD271+ bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis // Sci. Translat. Med.. – 2013. – Vol. 5, Iss. 170. – P. 170. doi: 10.1126/scitranslmed.3004912.Das B., Kashino S.S., Pulu I. et al. CD271+ bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis. Sci. Translat. Med., 2013, vol. 5, iss. 170, pp. 170. doi: 10.1126/scitranslmed.3004912.Espinal M. A., Laszlo A., Simonsen L. et al. Global trends in resistance to antituberculosis drugs // New Engl. J. Med. – 2001. – Vol. 344, Iss. 17. – P. 1294-1303. doi: 10.1056/NEJM200104263441706.Espinal M.A., Laszlo A., Simonsen L. et al. Global trends in resistance to antituberculosis drugs. New Engl. J. Med., 2001, vol. 344, iss. 17, pp. 1294-1303. doi: 10.1056/NEJM200104263441706.Fatima S., Kamble,S. S., Dwivedi V. P. et al. Mycobacterium tuberculosis programs mesenchymal stem cells to establish dormancy and persistence // J. Clin. Invest. – 2020. – Vol. 130, Iss. 2. – P. 655-661. doi: 10.1172/JCI128043.Fatima S., Kamble,S.S., Dwivedi V.P. et al. Mycobacterium tuberculosis programs mesenchymal stem cells to establish dormancy and persistence. J. Clin. Invest., 2020, vol. 130, iss. 2, pp. 655-661. doi: 10.1172/JCI128043.Gomez J. E., McKinney J. D. M. tuberculosis persistence, latency, and drug tolerance // Tuberculosis. – 2004. – Vol. 84, Iss. 1-2. – P. 29-44. doi:10.1016/j.tube.2003.08.003.Gomez J.E., McKinney J.D. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis, 2004, vol. 84, iss. 1-2. pp. 29-44. doi:10.1016/j.tube.2003.08.003.Gutierrez M. G., Master S. S., Singh S. B. et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages // Cell. – 2004. – Vol. 119, Iss. 6. – P. 753-766. doi:10.1016/j.cell.2004.11.038.Gutierrez M.G., Master S.S., Singh S.B. et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell, 2004, vol. 119, iss. 6, pp. 753-766. doi:10.1016/j.cell.2004.11.038.Islam M. N., Das S. R., Emin M. T. et al. Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury // Nature Med. – 2012. – Vol. 18, Iss. 5. – P. 759-765. doi:10.1038/nm.2736.Islam M.N., Das S.R., Emin M.T. et al. Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury. Nature Med., 2012, vol. 18, iss. 5, pp. 759-765. doi:10.1038/nm.2736.Khan A., Mann L., Papanna R. et al. Mesenchymal stem cells internalize Mycobacterium tuberculosis through scavenger receptors and restrict bacterial growth through autophagy // Sci. Reports. – 2017. – Vol. 7, Iss. 1. – P. 1-15. doi:10.1038/s41598-017-15290-z.Khan A., Mann L., Papanna R. et al. Mesenchymal stem cells internalize Mycobacterium tuberculosis through scavenger receptors and restrict bacterial growth through autophagy. Sci. Reports, 2017, vol. 7, iss. 1, pp. 1-15. doi:10.1038/s41598-017-15290-z.Levitte S., Adams K. N., Berg R. D. et al. Mycobacterial acid tolerance enables phagolysosomal survival and establishment of tuberculous infection in vivo // Cell Host & Microbe. – 2016. – Vol. 20, Iss. 2. – P. 250-258. doi:10.1016/j.chom.2016.07.007.Levitte S., Adams K.N., Berg R.D. et al. Mycobacterial acid tolerance enables phagolysosomal survival and establishment of tuberculous infection in vivo. Cell Host & Microbe, 2016, vol. 20, iss. 2, pp. 250-258. doi:10.1016/j.chom.2016.07.007.Matthay M. A., Goolaerts A., Howard J. P. et al. Mesenchymal Stem Cells for Acute Lung Injury: Preclinical Evidence // Crit. Care Med. – 2010. – Vol. 38, Iss. 10. – P. 569-573. doi: 10.1097/CCM.0b013e3181f1ff1d.Matthay M.A., Goolaerts A., Howard J.P. et al. Mesenchymal Stem Cells for Acute Lung Injury: Preclinical Evidence. Crit. Care Med., 2010, vol. 38, iss. 10, pp. 569-573. doi: 10.1097/CCM.0b013e3181f1ff1d.Mei S. H., McCarter S. D., Deng Y. et al. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1 // PLoS Med. – 2007. – Vol. 4, Iss. 9. – P. e269. doi:10.1371/journal.pmed.0040269.Mei S.H., McCarter S.D., Deng Y. et al. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med., 2007, vol. 4, iss. 9, pp. e269. doi:10.1371/journal.pmed.0040269.Parida S. K. Madansein R., Singh N. et al. Cellular therapy in tuberculosis // Intern. J. Infect. Dis. – 2015. – Vol. 32. – P. 32-38. doi:10.1016/j.ijid.2015.01.016.Parida S.K. Madansein R., Singh N. et al. Cellular therapy in tuberculosis. Intern. J. Infect. Dis., 2015, vol. 32, pp. 32-38. doi:10.1016/j.ijid.2015.01.016.Raghuvanshi S., Sharma P., Singh S. et al. Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells // Proceedings of the National Academy of Sciences. – 2010. – Vol. 107, Iss. 50. – P. 21653-21658. doi:10.1073/pnas.1007967107.Raghuvanshi S., Sharma P., Singh S. et al. Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. Proceedings of the National Academy of Sciences, 2010, vol. 107, iss. 50, pp. 21653-21658. doi:10.1073/pnas.1007967107.Shah N. S., Wright A., Bai G. H. et al. Worldwide emergence of extensively drug-resistant tuberculosis // Emerg. Infect. Dis. – 2007. – Vol. 13, Iss. 3. – P. 380. doi:10.3201/eid1303.061400.Shah N.S., Wright A., Bai G.H. et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis., 2007, vol. 13, iss. 3, pp. 380. doi:10.3201/eid1303.061400.Sinclair K., Yerkovich S. T., Chambers D. C. Mesenchymal stem cells and the lung // Respirology. – 2013. – Vol. 18, Iss. 3. – P. 397-411. doi:10.1111/resp.12050.Sinclair K., Yerkovich S.T., Chambers D.C. Mesenchymal stem cells and the lung. Respirology, 2013, vol. 18, iss. 3, pp. 397-411. doi:10.1111/resp.12050.Skrahin A., Ahmed R. K., Ferrara G. et al. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial // Lancet Respir. Med. – 2014. – Vol. 2, Iss. 2. – P. 108-122. doi:10.1016/S2213-2600(13)70234-0.Skrahin A., Ahmed R.K., Ferrara G. et al. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. Lancet Respir. Med., 2014, vol. 2, iss. 2, pp. 108-122. doi:10.1016/S2213-2600(13)70234-0.Spees J. L., Olson S. D., Whitney M. J. et al. Mitochondrial transfer between cells can rescue aerobic respiration // Proceedings of the National Academy of Sciences. – 2006. – Vol. 103, Iss. 5. – P. 1283-1288. doi:10.1073/pnas.0510511103.Spees J.L., Olson S.D., Whitney M.J. et al. Mitochondrial transfer between cells can rescue aerobic respiration. Proceedings of the National Academy of Sciences, 2006, vol. 103, iss. 5, pp. 1283-1288. doi:10.1073/pnas.0510511103.Sturgill-Koszycki S., Schlesinger P. H., Chakraborty P. et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase // Science. – 1994. – Vol. 263, Iss. 5147. – P. 678-681. doi: 10.1126/science.8303277.Sturgill-Koszycki S., Schlesinger P.H., Chakraborty P. et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science, 1994, vol. 263, iss. 5147, pp. 678-681. doi:10.1126/science.8303277.Tardif S., Ross C., Bergman P. et al. Testing efficacy of administration of the antiaging drug rapamycin in a nonhuman primate, the common marmoset // J. Gerontology Series A: Biomed. Sci. Med. Sci. – 2015. – Vol. 70, Iss. 5. – P. 577-588. doi:10.1093/gerona/glu101.Tardif S., Ross C., Bergman P. et al. Testing efficacy of administration of the antiaging drug rapamycin in a nonhuman primate, the common marmoset. J. Gerontology Series A: Biomed. Sci. Med. Sci., 2015, vol. 70, iss. 5, pp. 577-588. doi:10.1093/gerona/glu101.Tropea K. A., Leder E., Aslam M. et al. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia // Amer. J. Physiology-Lung Cell. Molec. Physiol. – 2012. – Vol. 302, Iss. 9. – P. 829-837. doi:10.1152/ajplung.00347.2011.Tropea K.A., Leder E., Aslam M. et al. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Amer. J. Physiology-Lung Cell Molec. Physiol., 2012, vol. 302, iss. 9, pp. 829-837. doi:10.1152/ajplung.00347.2011.van der Wel N., Hava D., Houben D. et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells // Cell. – 2007. – Vol. 129, Iss. 7. – P. 1287-1298. doi:10.1016/j.cell.2007.05.059.van der Wel N., Hava D., Houben D. et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell, 2007, vol. 129, iss. 7, pp. 1287-1298. doi:10.1016/j.cell.2007.05.059.Velayati A. A. et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran // Chest. – 2009. – Vol. 136, Iss. 2. – P. 420-425. doi:10.1378/chest.08-2427.Velayati A.A. et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest, 2009, vol. 136, iss. 2, pp. 420-425. doi:10.1378/chest.08-2427.Wakamoto Y., Dhar N., Chait R. et al. Dynamic persistence of antibiotic-stressed mycobacteria // Science. – 2013. – Vol. 339, Iss. 6115. – P. 91-95. doi:10.1126/science.1229858.Wakamoto Y., Dhar N., Chait R. et al. Dynamic persistence of antibiotic-stressed mycobacteria. Science, 2013, vol. 339, iss. 6115, pp. 91-95. doi: 10.1126/science.1229858.Yudintceva N. M., Bogolyubova I. O., Muraviov A. N. et al. Application of the allogenic mesenchymal stem cells in the therapy of the bladder tuberculosis // J. Tissue Eng. Regener. Med. – 2018. – Vol. 12, Iss. 3. – P. 1580-1593. doi:10.1002/term.2583.Yudintceva N.M., Bogolyubova I.O., Muraviov A.N. et al. Application of the allogenic mesenchymal stem cells in the therapy of the bladder tuberculosis. J. Tissue Eng. Regener. Med., 2018, vol. 12, iss. 3, pp. 1580-1593. doi:10.1002/term.2583.

The authors declare that there are no conflicts of interest present.